ORCID as entered in ROS

Select Publications
2019, 'PERCEPTIONS OF EXTENDED-RELEASE BUPRENORPHINE INJECTIONS FOR OPIOID DEPENDENCE PRIOR TO AVAILABILITY IN AUSTRALIA: A CROSS-SECTIONAL SURVEY OF PEOPLE WHO USE OPIOIDS REGULARLY', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 38, pp. S63 - S64
,2018, 'AN ANALYSIS OF CORRELATES AND REASONS FOR NOT SWABBING INJECTION SITES AMONG AUSTRALIANS WHO REGULARLY INJECT DRUGS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S44 - S44, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000113&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'NON-FATAL OVERDOSE PREVALENCE AMONG PEOPLE WHO INJECT DRUGS - A MULTI-STAGE SYSTEMATIC REVIEW AND META-ANALYSIS OF RECENT EVIDENCE', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 37, pp. S23 - S23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000449495000060&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'The safety of fentanyl patch initiation in Australian clinical practice: A population-based study', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 27, pp. 437 - 437, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000441893804049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Estimating the number of people who inject drugs and the coverage of harm reduction services in Canada', in JOURNAL OF VIRAL HEPATITIS, WILEY, CANADA, Toronto, Vol. 25, pp. 131 - 131, presented at 16th International Symposium on Viral Hepatitis and Liver Diseases (ISVHLD), CANADA, Toronto, 14 June 2018 - 17 June 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000435101000220&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'Comparing the prevention gains of different treatment strategies at the global, regional, and country level: a modelling study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, Vol. 68, pp. S179 - S180, presented at International Liver Congress (ILC), FRANCE, Paris, 11 April 2018 - 15 April 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000461068600354&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2018, 'The contribution of injecting drug use to Hepatitis C virus transmission globally, regionally, and at country level: a modelling study', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, FRANCE, Paris, Vol. 68, pp. S179 - S179, presented at International Liver Congress (ILC), FRANCE, Paris, 11 April 2018 - 15 April 2018, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000461068600353&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2017, 'A CROSS-SECTIONAL STUDY OF THE ASSOCIATION BETWEEN SELF-PERCEIVED HEPATITIS C VIRUS STATUS AND RECEPTIVE SYRINGE SHARING AMONG AUSTRALIANS WHOREGULARLY INJECT DRUGS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 36, pp. 24 - 24, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000424000500057&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2016, 'EXPOSURE TO OPIOID SUBSTITUTION THERAPY FOLLOWING HEPATITIS C NOTIFICATION: IMPLICATIONS FOR PROVISION OF ANTIVIRAL THERAPIES IN DRUG TREATMENT SETTINGS', in DRUG AND ALCOHOL REVIEW, WILEY, Vol. 35, pp. 48 - 48
,2016, 'Initiation Of Strong Prescription Opioids In Australia: Cohort Characteristics And Factors Associated With The Type Of Opioid Initiated', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY-BLACKWELL, Vol. 25, pp. 212 - 213, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000385483501355&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2020, A Data Linkage Evaluation of the Outcomes of the NSW Involuntary Drug and Alcohol Treatment (IDAT) Program, UNSW Social Policy Research Centre, Sydney, DPMP Monograph No. 33, http://dx.doi.org/10.26190/n165-xq68
,2019, Self-report and serological HCV status amongst people who inject drugs in NSW and ACT, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, Drug Trends Bulletin August 2019, http://dx.doi.org/10.26190/5d788a487ac61, https://ndarc.med.unsw.edu.au/sites/default/files/ndarc/resources/4.%20DBS%20and%20HCV%20self%20report%20bulletin.pdf
,2019, Use of alcohol swabs to clean injecting sites among people who regularly inject drugs in Australia, National Drug and Alcohol Research Centre, UNSW Sydney, Sydney, http://dx.doi.org/10.26190/5c92bc437e695
,2015, Patients motivations, perceptions and experiences of OST in prison report: Qualitative component
,2014, Determining the impact of opioid substitution therapy upon mortality and recidivism among prisoners: A 22 year data linkage study, National Drug and Alcohol Research Centre, University of New South Wales, Sydney, 330, https://ndarc.med.unsw.edu.au/resource/determining-impact-opioid-substitution-therapy-upon-mortality-and-recidivism-among
,2009, Magistrates Early Referral Into Treatment: Annual report 2007
,2009, Aboriginal participation in the MERIT program, 6, http://www.crimeprevention.nsw.gov.au/agdbasev7wr/_assets/cpd/m660001l2/issue_6_a4_merit_abr.pdf
,2009, Magistrates Early Referral Into Treatment: An overview of the MERIT program as at June 2009, 8, http://www.crimeprevention.nsw.gov.au/agdbasev7wr/_assets/cpd/m660001l2/merit_programreview_june_09_bulletin_final_forweb.pdf
,2009, Principal drug of concern: An analysis of MERIT and RAD client characteristics and outcomes, 7, http://www.crimeprevention.nsw.gov.au/agdbasev7wr/_assets/cpd/m660001l2/issue_7_a4_merit_drug.pdf
,2009, Women and the MERIT program, 5, http://www.crimeprevention.nsw.gov.au/agdbasev7wr/_assets/cpd/m660001l2/issue_5_a4_merit_bulleti_wom.pdf
,2008, Demand reduction strategies in closed settings in China, Indonesia and Viet Nam, National Drug and Alcohol Research Centre, Sydney, 291, http://ndarc.med.unsw.edu.au/sites/all/shared_files/ndarc/resources/TR.291.pdf
,2007, HIV prevention, treatment and care in prisons in South-east Asia, National Drug and Alcohol Research Centre, Sydney, NSW, 290, http://ndarc.med.unsw.edu.au/sites/all/shared_files/ndarc/resources/TR.290.pdf
,2006, A process evaluation of Gorman House detoxification service, National Drug and Alcohol Research Centre, Sydney, NSW, 260
,2006, The Integration of harm reduction into abstinence-based Therapeutic Communities: A Case Study of We Help Ourselves, National Drug and Alcohol Research Centre, Sydney, NSW, 263
,2021, Changes in youth mental health, psychological wellbeing, and substance use during the COVID-19 pandemic: A rapid review, http://dx.doi.org/10.31234/osf.io/yuthm
,